Malaysia grants conditional registration approval for Sinopharm, Johnson & Johnson's Janssen Covid-19 vaccines
KUALA LUMPUR (July 16): Malaysia has granted conditional registration approval for the use of the Sinopharm and Johnson & Johnson's Janssen Covid-19 vaccines to curb the spread of the pandemic, according to Health director-general Tan Sri Dr Noor Hisham Abdullah (pictured).